Suchergebnisse - "Mizrahi, Barak"

PubPharm (18)

1

The effect of mind-body intervention on lymphocyte doubling time and treatment free survival in treatment-naïve chronic lymphocytic leukemia patients

enthalten in: Acta haematologica | 2024

von Shapira, S. | Hirschberger, N. | Ofran, Y. | +5

2

Long covid outcomes at one year after mild SARS-CoV-2 infection : nationwide cohort study

enthalten in: BMJ (Clinical research ed.) | 2023

von Mizrahi, B. | Sudry, T. | Flaks-Manov, N. | +8

3

Results of an early second PCR test performed on SARS-CoV-2 positive patients may indicate risk for severe COVID-19

enthalten in: bioRxiv.org | 2022

von Mizrahi, B. | Bivas-Benita, M. | Kalkstein, N. | +7

4

BNT162b2 mRNA Vaccine Effectiveness Given Confirmed Exposure : Analysis of Household Members of Coronavirus Disease 2019 Patients

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Gazit, S. | Mizrahi, B. | Kalkstein, N. | +5

5

Robust antibody response after a third BNT162b2 vaccine compared to the second among immunocompromised and healthy individuals, a prospective longitudinal cohort study

enthalten in: Vaccine | 2022

von Shapiro Ben David, S. | Mizrahi, B. | Rahamim-Cohen, D. | +12

6

BNT162b2 mRNA Vaccine Effectiveness Given Confirmed Exposure; Analysis of Household Members of COVID-19 Patients

enthalten in: bioRxiv.org | 2022

von Gazit, S. | Mizrahi, B. | Kalkstein, N. | +4

7

Correlation of SARS-CoV-2 Breakthrough Infections to Time-from-vaccine; Preliminary Study

enthalten in: bioRxiv.org | 2022

von Mizrahi, B. | Lotan, R. | Kalkstein, N. | +6

8

BNT162b2 vaccine booster dose protection: A nationwide study from Israel

enthalten in: bioRxiv.org | 2021

von Bar-On, Y. | Goldberg, Y. | Mandel, M. | +8

9

Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine

enthalten in: Nature communications | 2021

von Mizrahi, B. | Lotan, R. | Kalkstein, N. | +6

10

Results of an early second PCR test performed on SARS-CoV-2 positive patients may support risk assessment for severe COVID-19

enthalten in: Scientific reports | 2021

von Mizrahi, B. | Bivas-Benita, M. | Kalkstein, N. | +7